Dr. Reddy’s Laboratories informs about press release

05 Jun 2025 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Alvotech and Dr. Reddy’s enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) for global markets.’
The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1274.50 -2.50 (-0.20%)
05-Dec-2025 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.50
Dr. Reddys Lab 1274.50
Cipla 1520.00
Zydus Lifesciences 930.75
Lupin 2098.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×